A team of engineers at Scripps Research has developed a kind of low-tech worming device that can be used to rapidly and reliably sterilize medical implants such as pacemaker implants heart valves and lenses.
In a paper published in the journal Angewandte Chemie International Edition the group describes their miniaturized nanocervel surface liquid-liquid-liquid-chambered (MLC) hydrogel which can be obtained from plastic and polymer and injected into wounds of mice.
Our gel is engineered in a way that it does not require firing can be injected over a long period of time and can be wound shut down through light says co-author Christophe Lebonheau PhD a professor of chemical and biological engineering at Scripps Research. MLC is characterized by low energy consumption relatively strong adhesive and does not affect tissue
He adds that the team is pursuing a goal of creating microfluidic devices (microfluidic devices or micro-devices) that are safe to be implanted in mammals for 20 to 30 days. As such it is possible to implant MLC in the body at any precise time without the need to change the implant material or the size of the crystalized surface.
This study provides a path that involves a very simple majority-rule injector microfluidic device and tiny needle glue Lebonheau says. Virtual reality would be a major step down to current technologies in microfluidic device manufacture and delivery.
Fujitsus INOCITE microelectronics group collaborated with the group of Shigehito Oshima PhD Hiroshi Miyauchi PhD and the team of Hideyuki Iwasaki PhD on the study.
In 2014 co-author Hiroshi Miyauchi PhD of Fujitsu International Research and Technology Center developed a system for nanoscale electrically conductive ink much like technology used in lasers for personal electronics design development.
In addition Phelan Smith Ph. D. of Cronos Biotech developed and implemented a nanoscale isolationpoint refractor to achieve microfluidic dispersion and to eliminate skin and other material conductivity.
These studies are presented as preprint in Angewandte Chemie International Edition.
Shigehito Oshima PhD Hiroshi Miyauchi PhD Hideyuki Iwasaki PhD Christophe Lebonheau PhD and Christophe Lebonheau PhD are co-principal investigators. Hans Worth Ph. D. of Cronos Biotech was also a co-author.